A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

scientific article published on 4 August 2006

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382
review articleQ7318358

External links are
P356DOI10.1093/HUMUPD/DML036
P698PubMed publication ID16891296
P5875ResearchGate publication ID6896212

P50authorB. C. J. M. FauserQ112562991
P2093author name stringEijkemans MJ
Visser GH
Hughes EG
Macklon NS
Boomsma CM
P433issue6
P921main subjecthuman pregnancyQ11995
polycystic ovary syndromeQ500816
meta-analysisQ815382
polycystic ovaryQ5547896
P304page(s)673-683
P577publication date2006-08-04
P1433published inHuman Reproduction UpdateQ15724523
P1476titleA meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
P478volume12

Reverse relations

cites work (P2860)
Q92188420A Slower Age-Related Decline in Treatment Outcomes After the First Ovarian Stimulation for in vitro Fertilization in Women With Polycystic Ovary Syndrome
Q38371865A comprehensive approach in diagnosing the polycystic ovary syndrome
Q45111540A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis
Q47578433A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome
Q46491999Abnormal Placentation Associated with Infertility as a Marker of Overall Health
Q35737821Adverse pregnancy and birth outcomes associated with underlying diagnosis with and without assisted reproductive technology treatment
Q35767806Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study
Q64107820Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally
Q54312191Analysis of mitochondrial DNA sequence variants in patients with polycystic ovary syndrome.
Q47629555Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
Q38812465Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?
Q37396144Assessment of growth and metabolism characteristics in offspring of dehydroepiandrosterone-induced polycystic ovary syndrome adults
Q38001860Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review
Q33736117Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.
Q34910971Bioinformatics approach reveals evidence for impaired endometrial maturation before and during early pregnancy in women who developed preeclampsia
Q35137230Birth weight and childhood growth in daughters of women with irregular menstrual cycles
Q34396231Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).
Q38297114British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice
Q29248890CLINICAL PRACTICE. Polycystic Ovary Syndrome
Q35589236Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia
Q39133343Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.
Q92194284Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis
Q50102650Cardiovascular and Metabolic Health of 74 Children From Women Previously Diagnosed With Polycystic Ovary Syndrome in Comparison With a Population-Based Reference Cohort
Q34258370Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes
Q92331086Child Health: Is It Really Assisted Reproductive Technology that We Need to Be Concerned About?
Q24235484Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
Q24240718Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
Q38376246Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Q36406468Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial
Q80832590Clomiphene citrate: an old favourite lives on
Q36161784Co-morbidity of cervical incompetence with polycystic ovarian syndrome (PCOS) negatively impacts prognosis: A retrospective analysis of 178 patients.
Q37226664Coagulation and fibrinolytic indices during the first trimester of pregnancy in women with polycystic ovary syndrome: a preliminary study
Q89625695Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT
Q60937952Comparison of uterine and ovarian stromal blood flow in patients with polycystic ovarian syndrome
Q26799566Complications and challenges associated with polycystic ovary syndrome: current perspectives
Q37965510Consensus on women's health aspects of polycystic ovary syndrome (PCOS).
Q36935506Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study.
Q46608748Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity
Q36812563Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome
Q44193673Contribution of method of conception on pregnancy outcome after the 11-13 weeks scan
Q35177925Correlation of endometrial glycodelin expression and pregnancy outcome in cases with polycystic ovary syndrome treated with clomiphene citrate plus metformin: a controlled study
Q37939291Current perspectives of insulin resistance and polycystic ovary syndrome
Q37230319Current trends in the treatment of polycystic ovary syndrome with desire for children
Q90801248Curtailing PCOS
Q34129292Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome
Q35763642Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep
Q48282250Diabetes risk in women with gestational diabetes mellitus and a history of polycystic ovary syndrome: a retrospective cohort study
Q33587845Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline
Q90725281Disordered Eating Behaviours and Eating Disorders in Women in Australia with and without Polycystic Ovary Syndrome: A Cross-Sectional Study
Q39177630Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome?
Q34603981Does IVF cleavage stage embryo quality affect pregnancy complications and neonatal outcomes in singleton gestations after double embryo transfers?
Q57910457Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes?
Q37118473Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal
Q92967176Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study
Q50212287Effect of GnRHR polymorphisms on in vitro fertilization and embryo transfer in patients with polycystic ovary syndrome
Q28834175Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Q62538125Effect of Type 2 Diabetes Mellitus on the Pharmacokinetics of Metformin in Obese Pregnant Women
Q37042367Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome
Q38660078Effect of maternal PCOS and PCOS-like phenotype on the offspring's health
Q26991523Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis
Q36923352Effectiveness of electroacupuncture for polycystic ovary syndrome: study protocol for a randomized controlled trial.
Q39041432Effects of Resveratrol on Ovarian Morphology, Plasma Anti-Mullerian Hormone, IGF-1 Levels, and Oxidative Stress Parameters in a Rat Model of Polycystic Ovary Syndrome.
Q38063567Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials
Q37256835Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis
Q46335947Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study
Q38600177Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis
Q92956492Environmental Toxins and Infertility
Q38007200Evidence-based lifestyle and pharmacological management of infertility in women with polycystic ovary syndrome
Q37764927Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
Q34305184Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring
Q37663309Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran
Q48686680Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates
Q34041888Fetal programming and metabolic syndrome
Q46371543Free radical scavenging window of infertile patients with polycystic ovary syndrome: correlation with embryo quality
Q24289192Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response
Q28291029Genetic variants and the risk of gestational diabetes mellitus: a systematic review
Q37049974Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.
Q26740034Genetic, hormonal and metabolic aspects of PCOS: an update
Q39038193Gestational Hyperandrogenism in Developmental Programming
Q44501348Group-based developmental BMI trajectories, polycystic ovary syndrome, and gestational diabetes: a community-based longitudinal study.
Q35107945Growth development of French children born after in vitro maturation.
Q46144968Haemoglobin, C-reactive protein and androgen levels in uncomplicated and complicated pregnancies of women with polycystic ovary syndrome
Q35738257HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome
Q27026624Health and fertility in World Health Organization group 2 anovulatory women
Q42905796Hormonal and metabolic characteristics of premenopausal women with a history of preeclamptic pregnancy
Q92003913How Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice?
Q36868187How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation
Q36661975Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study
Q24186095Hypoglycaemic agents for pregnant women with polycystic ovarian syndrome
Q24198844Hypoglycaemic agents for pregnant women with polycystic ovarian syndrome
Q33893011Identification and treatment of metabolic complications in pediatric obesity
Q34099068Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Q34604094Implication of SH2B1 gene polymorphism studies in gestational diabetes mellitus in Saudi pregnant women
Q38011264In vitro fertilisation: perinatal risks and early childhood outcomes
Q44119554In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes
Q51363991Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study.
Q33849481Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels
Q38591258Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome
Q50571045Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
Q33569169Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications
Q39026021Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies
Q38626489Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and 3 years of age.
Q36709715Intrauterine environment and polycystic ovary syndrome
Q64101187Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice
Q33617230Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical tri
Q37429919Live birth rates and birth outcomes by diagnosis using linked cycles from the SART CORS database
Q42282571Loss of Endometrial Sodium Glucose Cotransporter SGLT1 is Detrimental to Embryo Survival and Fetal Growth in Pregnancy.
Q44243871Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome
Q40680864Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions
Q36429617Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction
Q84888095Maternal obesity: the interplay between inflammation, mother and fetus
Q52580412Maternal polycystic ovarian syndrome and early offspring development.
Q88777815Maternal polycystic ovarian syndrome and offspring growth: the Upstate KIDS Study
Q37149626Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
Q40946230Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)
Q37412812Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
Q43166289Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome
Q50056205Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis
Q42868207Metformin Versus Placebo from First Trimester to Delivery in Polycystic Ovary Syndrome: A Randomized, Controlled Multicenter Study
Q22242884Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications
Q92324109Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression
Q47112166Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis
Q27000954Obesity and PCOS: implications for diagnosis and treatment
Q26830536Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome
Q37079215Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis
Q46655583Obstetric outcomes in women with polycystic ovary syndrome and isolated polycystic ovaries undergoing in vitro fertilization: a retrospective cohort analysis.
Q47857506Obstetrical complications in dichorionic twin pregnancies in women with polycystic ovary syndrome
Q57458409Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome
Q34673147Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration
Q33990127Overweight and Obesity before, during and after Pregnancy: Part 1: Pathophysiology, Molecular Biology and Epigenetic Consequences
Q38230280Oxidative stress in pregnancy and fertility pathologies
Q61854954PCOS and Pregnancy: Impact of Endocrine and Metabolic Factors
Q33816253PCOS--what matters in early pregnancy?--data from a cross-sectional, multicenter study
Q30371644Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.
Q38851128Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
Q50280323Placental characteristics in women with polycystic ovary syndrome
Q55395471Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review.
Q80844876Polycystic ovary syndrome
Q83062366Polycystic ovary syndrome
Q88098767Polycystic ovary syndrome
Q36935621Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles
Q38654905Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?
Q37699367Polycystic ovary syndrome and weight management
Q47915318Polycystic ovary syndrome throughout a woman's life
Q37585306Polycystic ovary syndrome, obesity and reproductive implications
Q38010787Polycystic ovary syndrome: a common but often unrecognized condition
Q38218598Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about
Q21245262Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
Q37832125Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Q39667906Polycystic ovary syndrome: infertility, cardiovascular, metabolic and obstetrical risks, laboratory and clinical outcomes -- the PICOLO Study
Q51005062Potent therapeutic effects of shouwu jiangqi decoction on polycystic ovary syndrome with insulin resistance in rats.
Q41244068Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study
Q38263893Pregnancy complications in polycystic ovary syndrome patients
Q26822402Pregnancy complications in women with polycystic ovary syndrome
Q36862243Pregnancy in polycystic ovary syndrome
Q34257603Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview
Q49959431Pregnancy-related outcomes for women with polycystic ovary syndrome
Q36152304Prevalence of cervical insufficiency in polycystic ovarian syndrome
Q44446725Prevalence of polycystic ovary syndrome in women in China: a large community-based study
Q34575260Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration
Q38365322ROLE OF INSULIN SENSITIZERS ON CARDIOVASCULAR RISK FACTORS IN POLYCYSTIC OVARIAN SYNDROME: A META-ANALYSIS.
Q28383112Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
Q35815740Relationship between Polycystic Ovarian Syndrome and Subsequent Gestational Diabetes Mellitus: A Nationwide Population-Based Study
Q56973886Reproductive endocrinology: Maternal and fetal insulin levels at birth in women with PCOS
Q85230833Reproductive endocrinology: revisiting ovulation induction in PCOS
Q33697865Risk factors for preeclampsia in infertile Chinese women with polycystic ovary syndrome: A prospective cohort study
Q39937391Risk factors for stillbirth in a socio-economically disadvantaged urban Australian population
Q36731528Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome
Q35340822Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study
Q36604066Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome
Q42820460Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome
Q36329913Role of metformin in the management of polycystic ovary syndrome
Q35049496Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history
Q37413767Sex hormone binding globulin measurement before conception as a predictor of gestational diabetes in women with polycystic ovarian syndrome
Q42859978Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome
Q37906977Sex steroid hormones and reproductive disorders: impact on women's health
Q47809914Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome
Q36943683Targets to treat metabolic syndrome in polycystic ovary syndrome
Q61453124The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort
Q35100131The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
Q37924338The consequences of obesity and excess weight gain in pregnancy
Q26784331The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol
Q37326585The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review
Q41204582The effects of polycystic ovary syndrome on gestational diabetes mellitus
Q33580018The experience of women affected by polycystic ovary syndrome: a qualitative study from iran
Q28396893The exposome--exciting opportunities for discoveries in reproductive and perinatal epidemiology
Q38924361The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
Q38229280The management of patients with polycystic ovary syndrome
Q62091537The ovarian dysgenesis syndrome
Q35841226The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome
Q50428675Therapeutic approach for metabolic disorders and infertility in women with PCOS.
Q36273439Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice
Q34574136Treatment options for polycystic ovary syndrome
Q30847984Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis
Q24234635Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
Q37769526Use of metformin in the treatment of polycystic ovary syndrome
Q53742992Valuable predictors of gestational diabetes mellitus in infertile Chinese women with polycystic ovary syndrome: a prospective cohort study.
Q41790078Weight Management Interventions in Women with and without PCOS: A Systematic Review
Q83030389[Definitions, epidemiology, risk factors]
Q51366656[Markers of diagnosis and treatment in 924 pregnancies with gestational diabetes mellitus].

Search more.